Veriff, an identity verification service, and Certific, a telemedicine testing service, have announced a partnership to improve and streamline Certific’s global expansion and telemedicine diagnosis capabilities. press release.
Veriff can verify over 10,000 identity documents from over 190 countries in nearly 45 languages.
Faster and easier identity verification
As the use of telemedicine continues to grow around the world, demand from patients for the option of digitally verifying their identity is increasing.
This protects privacy, associates correct medical history, and helps providers avoid fraud, malpractice, and other issues.
Certific customers can take advantage of Veriff’s cutting-edge, simple AI-powered identity verification technology. They enjoy a faster and easier identity verification process, building trust and reducing the risk of fraud in telemedicine testing.
Veriff CEO and Founder Kaarel Kotkas said:
The pandemic has forced companies to go digital faster than planned to remain competitive. As such, the demand for secure remote identity verification continues to grow in industries around the world, including healthcare services. Combining Veriff’s solutions with Certific’s telemedicine testing services, customers will be able to securely and efficiently access telemedicine services and personal medical records through cutting-edge biometric identity verification technology, empowering the digital healthcare process. Security risks can be greatly reduced.
Certific CEO Liis Narusk added:
Telemedicine services are in high demand and Veriff’s technology enables secure global expansion while minimizing the risk of mass identity fraud and medical malpractice. Customers will benefit from a faster identity verification process, and the platform’s data and integrity will be better protected.
Certific recently hit another milestone. The company raised his $7.4 million in an investment round led by European investment platform Plural to support product expansion, advance telemedicine diagnostics and expedite entry into new markets.





























